• LEUKINE® (sargramostim)
  • RSS
  • Twitter
  • Facebook
  • Email
  • LinkedIn
Partner Therapeutics
  • About PTx
    • Leadership
    • Compliance
    • Business Development
    • Careers
    • News
  • Products
    • sargramostim
  • Research
    • Our Approach
    • Clinical Trials
    • Publications
    • COVID-19
  • Medical Info
    • Medical Inquiries
  • Contact Us
    • Contact Information
    • Lexington, MA
    • Lynnwood, WA

jQuery3 – Full width image

Continue Reading →
10
JAN
2014
0

Search

Archives

  • September 2021 (1)
  • August 2021 (1)
  • June 2021 (1)
  • May 2021 (1)
  • April 2021 (1)
  • March 2021 (2)
  • February 2021 (2)
  • September 2020 (2)
  • August 2020 (2)
  • June 2020 (1)
  • May 2020 (1)
  • March 2020 (1)
  • November 2019 (1)
  • September 2019 (1)
  • November 2018 (1)
  • June 2018 (1)
  • May 2018 (1)
  • March 2018 (1)
  • February 2018 (3)
  • January 2018 (1)
 
 

Latest News

  •  

    BARDA and Partner Therapeutics foster a new partnership around their FDA-approved drug, Leukine® to improve patient care for sepsis patients

    ...

  •  

    “A Drug Before Its Time?” LEUKINE® systematic review highlights innate and adaptive immune activity that may improve cancer outcomes and reduce toxicity

    ...

  •  

    Second Randomized Trial of Leukine® (sargramostim) in COVID-19 Demonstrates Improvement in Lung Function

    ...


Join Our Team

Partner Therapeutics (PTx) is a commercial biotech committed to improving the lives of patients with cancer and other serious diseases. We're looking for passionate professionals to join us with expertise that spans the biopharma value chain.

 

View Current Openings
  © 2020 Partner Therapeutics, Inc.
  • Home
  • News
  • Privacy Policy
  • Terms of Use